Use of IGF-I for the manufacture of a preparation for treating and preventing secondary effects of hyperinsulinemia in diabetics treated with insulin.

摘要

The invention concerns a method for treating and preventing secondary effects of hyperinsulinemia by application of insulin-like growth factor I (IGF I), and pharmaceutical compositions comprising IGF I which are useful for this purpose.